NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析

◆英語タイトル:NeuroScientific Biopharmaceuticals Ltd (NSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH3594142FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NeuroScientific Biopharmaceuticals Ltd (NSB) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

NeuroScientific Biopharmaceuticals Ltd (NeuroScientific) develops novel pharmaceutical products that target neurological disorders which have high unmet medical needs. The company’s pipeline products include EmtinB therapeutic peptide which is being developed for the treatment of neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s Disease and degenerative conditions of the optic nerve. The company has partnerships with various institute such as Lion’s Eye Institute, and Menzies Institute for Medical Research among others for research and the development of its pipeline product. NeuroScientific is headqutered in Nedlands, Western Australia, Australia.

NeuroScientific Biopharmaceuticals Ltd Key Recent Developments

Sep 25,2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25,2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30,2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
NeuroScientific Biopharmaceuticals Ltd – Key Facts
NeuroScientific Biopharmaceuticals Ltd – Key Employees
NeuroScientific Biopharmaceuticals Ltd – Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd – Major Products and Services
NeuroScientific Biopharmaceuticals Ltd – History
NeuroScientific Biopharmaceuticals Ltd – Company Statement
NeuroScientific Biopharmaceuticals Ltd – Locations And Subsidiaries
Head Office
Section 2 – Company Analysis
Company Overview
NeuroScientific Biopharmaceuticals Ltd – Business Description
NeuroScientific Biopharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
NeuroScientific Biopharmaceuticals Ltd – Strengths
NeuroScientific Biopharmaceuticals Ltd – Weaknesses
NeuroScientific Biopharmaceuticals Ltd – Opportunities
NeuroScientific Biopharmaceuticals Ltd – Threats
NeuroScientific Biopharmaceuticals Ltd – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Change of Registered Office and Principal Place of Business Address
Sep 25, 2020: NeuroScientific Biopharmaceuticals : Tax incentive rebate received
Jul 30, 2020: NeuroScientific Biopharmaceuticals announces professor Dao-Yi Yu of Lions Eye Institute appointed to Scientific Advisory Board
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
NeuroScientific Biopharmaceuticals Ltd, Key Facts
NeuroScientific Biopharmaceuticals Ltd, Key Employees
NeuroScientific Biopharmaceuticals Ltd, Key Employee Biographies
NeuroScientific Biopharmaceuticals Ltd, Major Products and Services
NeuroScientific Biopharmaceuticals Ltd, History
NeuroScientific Biopharmaceuticals Ltd, Key Competitors
NeuroScientific Biopharmaceuticals Ltd, Ratios based on current share price
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios
NeuroScientific Biopharmaceuticals Ltd, Annual Ratios (Cont...1)
NeuroScientific Biopharmaceuticals Ltd, Interim Ratios
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
NeuroScientific Biopharmaceuticals Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[NeuroScientific Biopharmaceuticals Ltd (NSB):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Activision Blizzard, Inc.
    Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report Summary Activision Blizzard, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Global Ports Holding PLC (GPH):企業の財務・戦略的SWOT分析
    Global Ports Holding PLC (GPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Engie SA (ENGI)-エネルギー分野:企業M&A・提携分析
    Summary Engie S.A. (Engie), formerly GDF Suez S.A., is an electric utility, which generates and distributes electricity and natural gas. It generates electricity using various sources including hydro, wind, solar, biomass, geothermal, nuclear, coal and fuel oil. The company supplies, distributes, tr …
  • CynergisTek, Inc. (CTEK):企業の戦略的SWOT分析
    CynergisTek, Inc. (CTEK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • University of Maryland Medical Center Corp:企業の戦略的SWOT分析
    University of Maryland Medical Center Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Volta River Authority:企業の戦略的SWOT分析
    Volta River Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Worldpay Group Ltd:企業の戦略・SWOT・財務分析
    Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Worldpay Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • UltraTech Cement Ltd:戦略・SWOT・企業財務分析
    UltraTech Cement Ltd - Strategy, SWOT and Corporate Finance Report Summary UltraTech Cement Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Sangui BioTech International Inc (SGBI):企業の財務・戦略的SWOT分析
    Sangui BioTech International Inc (SGBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Caltex Australia Ltd (CTX):石油・ガス:M&Aディール及び事業提携情報
    Summary Caltex Australia Ltd (Caltex) is a supplier of transport fuels and convenience retailer. The company purchases, refines, distributes and markets petroleum products. It supplies liquefied petroleum gas (LPG), petrol, diesel, jet fuel, lubricants, greases, fuel oil and specialty products. The …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務情報
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • OraMetrix Inc-医療機器分野:企業M&A・提携分析
    Summary OraMetrix Inc (OraMetrix) is a healthcare technology company that provides 3-D technology solutions. The company offers orthodontic treatment system and digital lingual orthodontic system. Its product allows the use of precision digital tools throughout the orthodontic treatment process incl …
  • Trustwave Holdings Inc:企業の戦略的SWOT分析
    Trustwave Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Petroleos de Venezuela SA:企業の戦略的SWOT分析
    Petroleos de Venezuela SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • KINeSYS Inc.:企業の戦略・SWOT・財務分析
    KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report Summary KINeSYS Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Unique Catering & Management Services Ltd:企業の戦略・SWOT・財務情報
    Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report Summary Unique Catering & Management Services Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Cerus Corp (CERS):医療機器:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Itausa – Investimentos Itau SA (ITSA4):企業の財務・戦略的SWOT分析
    Itausa - Investimentos Itau SA (ITSA4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Geron Corp (GERN):製薬・医療:M&Aディール及び事業提携情報
    Summary Geron Corp (Geron) is a clinical stage biopharmaceutical company, which develops a telomerase inhibitor as a potential treatment for cancer. The company is evaluating its flagship product candidate Imetelstat in two clinical trials: IMbark and IMerge in partnership with Janssen Biotech, Inc. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆